PFGIA
IPSC icon

Patriot Financial Group Insurance Agency’s Century Therapeutics IPSC Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-65
Closed -$1K – 1149
2022
Q2 		$1K Hold
65
– – ﹤0.01% 1907
2022
Q1 		$1K Hold
65
– – ﹤0.01% 1948
2021
Q4 		$1K Hold
65
– – ﹤0.01% 2044
2021
Q3 		$2K Buy
+65
New +$1.76K ﹤0.01% 1943

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Patriot Financial Group Insurance Agency's IPSC Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Century Therapeutics (IPSC) in Q3 2022, closing a stake of 65 shares — an estimated $1K sold.

Patriot Financial Group Insurance Agency first reported a position in IPSC in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 54 funds tracked by Wall St. Rank hold IPSC as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Century Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 65 Century Therapeutics shares in Q3 2022, an estimated $1K.
  • Patriot Financial Group Insurance Agency first reported a position in Century Therapeutics in Q3 2021 and held it in 4 quarters.
  • Patriot Financial Group Insurance Agency's Century Therapeutics position peaked at $2K in Q3 2021.
  • 54 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.